Your account is not claimed yet. You can sign up with ORCID to claim your account.

Dolors Colomer

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 27

Top Venues

Leukemia

Cancers

Current oncology (Toronto, Ont.)

Journal of experimental & clinical cancer research : CR

University of Barcelona

UNIVERSITY OF BARCELONA (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Barcelona Sep 1o 2018

Spain

Associate Professor :: Foanments Clinics

Education History

UNIVERSITY OF BARCELONA

Spain

PHD :: FACULTY OF CHEMISTRY (BIOCHEMISTRY)

Publications

Francisca Guijarro, Marta Garrote, Neus Villamor, Dolors Colomer, Jordi Esteve, Mónica López-Guerra
Novel Tools for Diagnosis and Monitoring of AML. Current oncology (Toronto, Ont.) 30 (6) (2023)
Francisca Guijarro, Marta Garrote, Neus Villamor, Dolors Colomer, Jordi Esteve, Mónica López-Guerra
Novel Tools for Diagnosis and Monitoring of AML. Current oncology (Toronto, Ont.) 30 (6) (2023)
Francisca Guijarro, Marta Garrote, Neus Villamor, Dolors Colomer, Jordi Esteve, Mónica López-Guerra
Novel Tools for Diagnosis and Monitoring of AML. Current oncology (Toronto, Ont.) 30 (6) (2023)
Irene López-Oreja, André Gohr, Heribert Playa-Albinyana, Ariadna Giró, Fabian Arenas, Morihiro Higashi, Rupal Tripathi, Mònica López-Guerra, Manuel Irimia, Marta Aymerich, Juan Valcárcel, Sophie C Bonnal, Dolors Colomer
SF3B1 mutation-mediated sensitization to H3B-8800 splicing inhibitor in chronic lymphocytic leukemia. Life science alliance 6 (11) (2023)
Marta Garrote, Mónica López-Guerra, Eduardo Arellano-Rodrigo, María Rozman, Sara Carbonell, Francisca Guijarro, Marta Santaliestra, Ana Triguero, Dolors Colomer, Francisco Cervantes, Alberto Álvarez-Larrán
Clinical Characteristics and Outcomes of Patients with Primary and Secondary Myelofibrosis According to the Genomic Classification Using Targeted Next-Generation Sequencing. Cancers 15 (15) (2023)
Francisca Guijarro, Marta Garrote, Neus Villamor, Dolors Colomer, Jordi Esteve, Mónica López-Guerra
Novel Tools for Diagnosis and Monitoring of AML. Current oncology (Toronto, Ont.) 30 (6) (2023)
Heribert Playa-Albinyana, Fabian Arenas, Romina Royo, Ariadna Giró, Irene López-Oreja, Marta Aymerich, Mònica López-Guerra, Gerard Frigola, Sílvia Beà, Julio Delgado, Pablo M Garcia-Roves, Elias Campo, Ferran Nadeu, Dolors Colomer
Chronic lymphocytic leukemia patient-derived xenografts recapitulate clonal evolution to Richter transformation. Leukemia (2023)
Ferran Araujo-Ayala, Cèlia Dobaño-López, Juan Garcia Valero, Ferran Nadeu, Fabien Gava, Carla Faria, Marine Norlund, Renaud Morin, Pascale Bernes-Lasserre, Neus Serrat, Heribert Playa-Albinyana, Rubén Giménez, Elias Campo, Jean-Michel Lagarde, Armando López-Guillermo, Eva Gine, Dolors Colomer, Christine Bezombes, Patricia Pérez-Galán
A novel patient-derived 3D model recapitulates mantle cell lymphoma lymph node signaling, immune profile and in vivo ibrutinib responses. Leukemia (2023)
Julia Salmerón-Villalobos, Caoimhe Egan, Vanessa Borgmann, Inga Müller, Blanca Gonzalez-Farre, Joan Enric Ramis-Zaldivar, Dominik Nann, Olga Balagué, Mónica López-Guerra, Dolors Colomer, Ilske Oschlies, Wolfram Klapper, Selina Glaser, Young-Hyeh Ko, Irina Bonzheim, Reiner Siebert, Falko Fend, Stefania Pittaluga, Elias Campo, Itziar Salaverria, Elaine S Jaffe, Leticia Quintanilla-Martínez
A unifying hypothesis for PNMZL and PTFL: morphological variants with a common molecular profile. Blood advances 6 (16) (2022)
Julia Salmerón-Villalobos, Joan Enric Ramis-Zaldivar, Olga Balagué, Jaime Verdú-Amorós, Verónica Celis, Constantino Sábado, Marta Garrido, Sara Mato, Javier Uriz, M José Ortega, Angela Gutierrez-Camino, Daniel Sinnett, Unai Illarregi, Maxime Caron, Alexandra Regueiro, Ana María Galera, Blanca Gonzalez-Farre, Elias Campo, Noelia Garcia, Dolors Colomer, Itziar Astigarraga, Mara Andrés, Margarita Llavador, Idoia Martin-Guerrero, Itziar Salaverria
Diverse mutations and structural variations contribute to Notch signaling deregulation in paediatric T-cell lymphoblastic lymphoma. Pediatric blood & cancer 69 (11) (2022)
Matthew Salmon, Helen E White, Hana Zizkova, Andrea Gottschalk, Eliska Motlova, Nuno Cerveira, Dolors Colomer, Daniel Coriu, Georg-Nikolaus Franke, Enrico Gottardi, Barbara Izzo, Tomas Jurcek, Thomas Lion, Vivien Schäfer, Claudia Venturi, Paolo Vigneri, Magdalena Zawada, Jan Zuna, Lenka Hovorkova, Jitka Koblihova, Hana Klamova, Marketa Stastna Markova, Dana Srbova, Adela Benesova, Vaclava Polivkova, Daniela Zackova, Jiri Mayer, Ingo Roeder, Ingmar Glauche, Thomas Ernst, Andreas Hochhaus, Katerina Machova Polakova, Nicholas C P Cross
Impact of BCR::ABL1 transcript type on RT-qPCR amplification performance and molecular response to therapy. Leukemia 36 (7) (2022)
Ferran Nadeu, Romina Royo, Ramon Massoni-Badosa, Heribert Playa-Albinyana, Beatriz Garcia-Torre, Martí Duran-Ferrer, Kevin J Dawson, Marta Kulis, Ander Diaz-Navarro, Neus Villamor, Juan L Melero, Vicente Chapaprieta, Ana Dueso-Barroso, Julio Delgado, Riccardo Moia, Sara Ruiz-Gil, Domenica Marchese, Ariadna Giró, Núria Verdaguer-Dot, Mónica Romo, Guillem Clot, Maria Rozman, Gerard Frigola, Alfredo Rivas-Delgado, Tycho Baumann, Miguel Alcoceba, Marcos González, Fina Climent, Pau Abrisqueta, Josep Castellví, Francesc Bosch, Marta Aymerich, Anna Enjuanes, Sílvia Ruiz-Gaspà, Armando López-Guillermo, Pedro Jares, Sílvia Beà, Salvador Capella, Josep Ll Gelpí, Núria López-Bigas, David Torrents, Peter J Campbell, Ivo Glynne Gut, Davide Rossi, Gianluca Gaidano, Xose S Puente, Pablo M García-Rovés, Dolors Colomer, Holger Heyn, Francesco Maura, José Ignacio Martin-Subero, Elias Campo
Detection of early seeding of Richter transformation in chronic lymphocytic leukemia. Nature medicine 28 (8) (2022)
Helen E White, Matthew Salmon, Francesco Albano, Christina Søs Auður Andersen, Stefan Balabanov, Gueorgui Balatzenko, Gisela Barbany, Jean-Michel Cayuela, Nuno Cerveira, Pascale Cochaux, Dolors Colomer, Daniel Coriu, Joana Diamond, Christian Dietz, Stephanie Dulucq, Marie Engvall, Georg N Franke, Egle Gineikiene-Valentine, Michał Gniot, María Teresa Gómez-Casares, Enrico Gottardi, Chloe Hayden, Sandrine Hayette, Andreas Hedblom, Anca Ilea, Barbara Izzo, Antonio Jiménez-Velasco, Tomas Jurcek, Veli Kairisto, Stephen E Langabeer, Thomas Lion, Nora Meggyesi, Semir Mešanović, Luboslav Mihok, Gerlinde Mitterbauer-Hohendanner, Sylvia Moeckel, Nicole Naumann, Olivier Nibourel, Elisabeth Oppliger Leibundgut, Panayiotis Panayiotidis, Helena Podgornik, Christiane Pott, Inmaculada Rapado, Susan J Rose, Vivien Schäfer, Tasoula Touloumenidou, Christopher Veigaard, Bianca Venniker-Punt, Claudia Venturi, Paolo Vigneri, Ingvild Vorkinn, Elizabeth Wilkinson, Renata Zadro, Magdalena Zawada, Hana Zizkova, Martin C Müller, Susanne Saussele, Thomas Ernst, Katerina Machova Polakova, Andreas Hochhaus, Nicholas C P Cross
Standardization of molecular monitoring of CML: results and recommendations from the European treatment and outcome study. Leukemia 36 (7) (2022)
Sandra Castaño-Díez, Mónica López-Guerra, Cristina Bosch-Castañeda, Alex Bataller, Paola Charry, Daniel Esteban, Francisca Guijarro, Carlos Jiménez-Vicente, Carlos Castillo, Albert Cortes, Alexandra Martínez-Roca, Ana Triguero, José Ramón Álamo, Silvia Beà, Dolors Costa, Dolors Colomer, María Rozman, Jordi Esteve, Marina Díaz-Beyá
Real-World Data on Chronic Myelomonocytic Leukemia: Clinical and Molecular Characteristics, Treatment, Emerging Drugs, and Patient Outcomes. Cancers 14 (17) (2022)
Heribert Playa-Albinyana, Fabián Arenas, Dolors Colomer
Advantages and disadvantages of mouse models of chronic lymphocytic leukemia in drug discovery. Expert opinion on drug discovery 16 (10) (2021)
Juan Garcia Valero, Alba Matas-Céspedes, Fabián Arenas, Vanina Rodriguez, Joaquim Carreras, Neus Serrat, Martina Guerrero-Hernández, Anella Yahiaoui, Olga Balagué, Silvia Martin, Cristina Capdevila, Lluis Hernández, Laura Magnano, Alfredo Rivas-Delgado, Stacey Tannheimer, Maria C Cid, Elias Campo, Armando López-Guillermo, Dolors Colomer, Patricia Pérez-Galán
The receptor of the colony-stimulating factor-1 (CSF-1R) is a novel prognostic factor and therapeutic target in follicular lymphoma. Leukemia 35 (9) (2021)
Gabriela Bastidas-Mora, Sílvia Beà, Alba Navarro, Eva Gine, Dolors Costa, Julio Delgado, Tycho Baumann, Laura Magnano, Alfredo Rivas-Delgado, Neus Villamor, Dolors Colomer, Mónica López-Guerra, María Rozman, Olga Balagué, Daniel Martinez, Maria Joao Baptista, Lourdes Escoda, Miguel Alcoceba, Margarita Blanes, Fina Climent, Elias Campo, Andrew Wotherspoon, Armondo López-Guillermo, Estella Matutes
Clinico-biological features and outcome of patients with splenic marginal zone lymphoma with histological transformation. British journal of haematology (2021)
Roser Vilarrasa-Blasi, Paula Soler-Vila, Núria Verdaguer-Dot, Núria Russiñol, Marco Di Stefano, Vicente Chapaprieta, Guillem Clot, Irene Farabella, Pol Cuscó, Marta Kulis, Xabier Agirre, Felipe Prosper, Renée Beekman, Sílvia Beà, Dolors Colomer, Hendrik G Stunnenberg, Ivo Glynne Gut, Elias Campo, Marc A Marti-Renom, José Ignacio Martin-Subero
Dynamics of genome architecture and chromatin function during human B cell differentiation and neoplastic transformation. Nature communications 12 (1) (2021)
Andrea Rivero, Pablo Mozas, Laura Jiménez, Mónica López-Guerra, Dolors Colomer, Alex Bataller, Juan Correa, Alfredo Rivas-Delgado, Gabriela Bastidas, Tycho Baumann, Alejandra Martínez-Trillos, Julio Delgado, Eva Giné, Elías Campo, Armando López-Guillermo, Neus Villamor, Laura Magnano, Estella Matutes
Clinicobiological Characteristics and Outcomes of Patients with T-Cell Large Granular Lymphocytic Leukemia and Chronic Lymphoproliferative Disorder of Natural Killer Cells from a Single Institution. Cancers 13 (15) (2021)
Philipp M Roessner, Laura Llaó Cid, Ekaterina Lupar, Tobias Roider, Marie Bordas, Christoph Schifflers, Lavinia Arseni, Ann-Christin Gaupel, Fabian Kilpert, Marit Krötschel, Sebastian J Arnold, Leopold Sellner, Dolors Colomer, Stephan Stilgenbauer, Sascha Dietrich, Peter Lichter, Ana Izcue, Martina Seiffert
EOMES and IL-10 regulate antitumor activity of T regulatory type 1 CD4+ T cells in chronic lymphocytic leukemia. Leukemia 35 (8) (2021)
Roser Vilarrasa-Blasi, Núria Verdaguer-Dot, Laura Belver, Paula Soler-Vila, Renée Beekman, Vicente Chapaprieta, Marta Kulis, Ana C Queirós, Maribel Parra, María-José Calasanz, Xabier Agirre, Felipe Prosper, Sílvia Beà, Dolors Colomer, Marc A Marti-Renom, Adolfo A Ferrando, Elias Campo, José Ignacio Martin-Subero
Insights into the mechanisms underlying aberrant SOX11 oncogene expression in mantle cell lymphoma. Leukemia (2021)
Laura Llaó-Cid, Philipp M Roessner, Vicente Chapaprieta, Selcen Öztürk, Tobias Roider, Marie Bordas, Ana Izcue, Dolors Colomer, Sascha Dietrich, Stephan Stilgenbauer, Bola Hanna, José Ignacio Martin-Subero, Martina Seiffert
EOMES is essential for antitumor activity of CD8+ T cells in chronic lymphocytic leukemia. Leukemia 35 (11) (2021)
Irene López-Oreja, Heribert Playa-Albinyana, Fabián Arenas, Mónica López-Guerra, Dolors Colomer
Challenges with Approved Targeted Therapies against Recurrent Mutations in CLL: A Place for New Actionable Targets. Cancers 13 (13) (2021)
Eriong Lee-Vergés, Bola S Hanna, Haniyeh Yazdanparast, Vanina Rodríguez, Marta Leonor Rodríguez, Ariadna Giró, Anna Vidal-Crespo, Laia Rosich, Virginia Amador, Marta Aymerich, Neus Villamor, Julio Delgado, Peter Lichter, Patricia Pérez-Galán, Mònica López-Guerra, Elías Campo, Martina Seiffert, Dolors Colomer
Selective BTK inhibition improves bendamustine therapy response and normalizes immune effector functions in chronic lymphocytic leukemia. International journal of cancer 144 (11) (2019)
Neus Giménez, Ralph Schulz, Morihiro Higashi, Marta Aymerich, Neus Villamor, Julio Delgado, Manel Juan, Mònica López-Guerra, Elias Campo, Laia Rosich, Martina Seiffert, Dolors Colomer
Targeting IRAK4 disrupts inflammatory pathways and delays tumor development in chronic lymphocytic leukemia. Leukemia 34 (1) (2019)
Mónica López-Guerra, Sílvia Xargay-Torrent, Patricia Fuentes, Jocabed Roldán, Blanca González-Farré, Laia Rosich, Elisabeth Silkenstedt, María J García-León, Eriong Lee-Vergés, Neus Giménez, Ariadna Giró, Marta Aymerich, Neus Villamor, Julio Delgado, Armando López-Guillermo, Xose S Puente, Elias Campo, María Luisa Toribio, Dolors Colomer
Specific NOTCH1 antibody targets DLL4-induced proliferation, migration, and angiogenesis in NOTCH1-mutated CLL cells. Oncogene 39 (6) (2019)
Elisabeth Silkenstedt, Fabian Arenas, Berta Colom-Sanmartí, Sílvia Xargay-Torrent, Morihiro Higashi, Ariadna Giró, Vanina Rodriguez, Patricia Fuentes, Walter E Aulitzky, Heiko van der Kuip, Sílvia Beà, Maria L Toribio, Elias Campo, Mònica López-Guerra, Dolors Colomer
Notch1 signaling in NOTCH1-mutated mantle cell lymphoma depends on Delta-Like ligand 4 and is a potential target for specific antibody therapy. Journal of experimental & clinical cancer research : CR 38 (1) (2019)

Dolors Colomer.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Dolors Colomer